✦ LIBER ✦

A phase II dose finding study of darbepoetin alpha and filgrastim for the management of anaemia and neutropenia in chronic hepatitis C treatment

✍ Scribed by Z. M. Younossi; F. H. Nader; C. Bai; R. Sjogren; J. P. Ong; R. Collantes; M. Sjogren; D. Farmer; L. Ramsey; K. Terra; H. Gujral; C. Gurung; M. Srishord; Y. Fang

Book ID: 108886109
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 165 KB
Volume: 15
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2007.00956.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose darbepoetin alpha in the treat

High-dose darbepoetin alpha in the treatment of anaemia of lower risk myelodysplastic syndrome results of a phase II study

✍ L. Mannone; C. Gardin; M. C. Quarre; J. F. Bernard; D. Vassilieff; L. Ades; S. P 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

The safety of pegylated interferon alpha

The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation

✍ M. van Zonneveld; H. J. Flink; E. Verhey; H. Senturk; S. Zeuzem; U. S. Akarca; Y 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

Critical review of the use of erythropoi

Critical review of the use of erythropoietin in the treatment of anaemia during therapy for chronic hepatitis C

✍ F. Stickel; B. Helbling; M. Heim; A. Geier; C. Hirschi; B. Terziroli; K. Wehr; A 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Daily dose of interferon alpha-2b and ri

Daily dose of interferon alpha-2b and ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection: a randomised controlled study

✍ GianPiero Benetti; Mauro Borzio; Giuliano Ramella; Giorgio Bellati; Silvia Fargi 📂 Article 📅 2006 🏛 Springer Milan 🌐 English ⚖ 98 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled clinical trial of high-dose interferon-alpha induction treatment combined with ribavirin for chronic hepatitis C in hemophilia

✍ K. Meijer; E. B. Haagsma; J. Van Der Meer; for the CHARIBDIS Study Group 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB

Safety and efficacy of an escalating dos

Safety and efficacy of an escalating dose regimen of pegylated interferon alpha-2b in the treatment of haemodialysis patients with chronic hepatitis C

✍ S. S. Tan; M. R. Abu Hassan; A. Abdullah; B. P. Ooi; T. Korompis; M. I. Merican 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB